Peguy Jean Pierre

Array ( [id] => 4199260 [patent_doc_number] => 06013665 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides' [patent_app_type] => 1 [patent_app_number] => 8/991503 [patent_app_country] => US [patent_app_date] => 1997-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7163 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013665.pdf [firstpage_image] =>[orig_patent_app_number] => 991503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4052390 [patent_doc_number] => 05932585 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Method of treating or inhibiting neutropenia' [patent_app_type] => 1 [patent_app_number] => 8/991424 [patent_app_country] => US [patent_app_date] => 1997-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3021 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 252 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932585.pdf [firstpage_image] =>[orig_patent_app_number] => 991424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994125 [patent_doc_number] => 05919781 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Use of NK-1 receptor antogonists for treating substance use disorders' [patent_app_type] => 1 [patent_app_number] => 8/980927 [patent_app_country] => US [patent_app_date] => 1997-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12584 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919781.pdf [firstpage_image] =>[orig_patent_app_number] => 980927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3956447 [patent_doc_number] => 05935980 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Use of pyrrolidine derivatives in the treatment of alcoholism' [patent_app_type] => 1 [patent_app_number] => 8/952937 [patent_app_country] => US [patent_app_date] => 1997-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2665 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 846 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935980.pdf [firstpage_image] =>[orig_patent_app_number] => 952937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4198914 [patent_doc_number] => 06013645 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives' [patent_app_type] => 1 [patent_app_number] => 8/913006 [patent_app_country] => US [patent_app_date] => 1997-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11293 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013645.pdf [firstpage_image] =>[orig_patent_app_number] => 913006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4003647 [patent_doc_number] => 05859037 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Sulfonylurea-glitazone combinations for diabetes' [patent_app_type] => 1 [patent_app_number] => 8/970057 [patent_app_country] => US [patent_app_date] => 1997-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 5 [patent_no_of_words] => 14966 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859037.pdf [firstpage_image] =>[orig_patent_app_number] => 970057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177209 [patent_doc_number] => 06019975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Antisebum and antioxidant compositions containing a low molecular weight fraction of gugulipid' [patent_app_type] => 1 [patent_app_number] => 8/969263 [patent_app_country] => US [patent_app_date] => 1997-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6072 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/019/06019975.pdf [firstpage_image] =>[orig_patent_app_number] => 969263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3905320 [patent_doc_number] => 06001345 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Application of cyanoacrylate/anti-microbial compositions to the peri-wound or peri-mucosal area' [patent_app_type] => 1 [patent_app_number] => 8/963180 [patent_app_country] => US [patent_app_date] => 1997-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5750 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001345.pdf [firstpage_image] =>[orig_patent_app_number] => 963180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4065047 [patent_doc_number] => 05866598 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Medicament for treating or preventing cerebrovascular dementia' [patent_app_type] => 1 [patent_app_number] => 8/958317 [patent_app_country] => US [patent_app_date] => 1997-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2821 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866598.pdf [firstpage_image] =>[orig_patent_app_number] => 958317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4126692 [patent_doc_number] => 06127342 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Method for preventing or treating a lung disease caused by active oxygen and free radical injury' [patent_app_type] => 1 [patent_app_number] => 8/951307 [patent_app_country] => US [patent_app_date] => 1997-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 5 [patent_no_of_words] => 6942 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127342.pdf [firstpage_image] =>[orig_patent_app_number] => 951307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3838209 [patent_doc_number] => 05846966 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/953825 [patent_app_country] => US [patent_app_date] => 1997-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13130 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 585 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846966.pdf [firstpage_image] =>[orig_patent_app_number] => 953825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047137 [patent_doc_number] => 05932247 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Pharmaceutical composition for piperidinoalkanol compounds' [patent_app_type] => 1 [patent_app_number] => 8/948005 [patent_app_country] => US [patent_app_date] => 1997-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15337 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932247.pdf [firstpage_image] =>[orig_patent_app_number] => 948005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946666 [patent_doc_number] => 05998423 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Methods for modulating melanin production' [patent_app_type] => 1 [patent_app_number] => 8/940338 [patent_app_country] => US [patent_app_date] => 1997-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 4468 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998423.pdf [firstpage_image] =>[orig_patent_app_number] => 940338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048320 [patent_doc_number] => 05968900 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Increasing creatine and glycogen concentration in muscle' [patent_app_type] => 1 [patent_app_number] => 8/875326 [patent_app_country] => US [patent_app_date] => 1997-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 3591 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968900.pdf [firstpage_image] =>[orig_patent_app_number] => 875326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771346 [patent_doc_number] => 05849789 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for the prophylaxis and treatment of reduced cerebral blood supply' [patent_app_type] => 1 [patent_app_number] => 8/937420 [patent_app_country] => US [patent_app_date] => 1997-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1926 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849789.pdf [firstpage_image] =>[orig_patent_app_number] => 937420 [rel_patent_id] =>[rel_patent_doc_number] =>)